AngioDynamics Inc (STU:UG2)
€ 5.9 0.05 (0.85%) Market Cap: 229.90 Mil Enterprise Value: 181.36 Mil PE Ratio: 0 PB Ratio: 1.16 GF Score: 57/100

AngioDynamics Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 14, 2021 / 07:50PM GMT
Release Date Price: €15.2
Unidentified Analyst

Thank you, everyone, for joining today. My name is [Soren Merle]. I'm an associate on the medtech team here at JPMorgan. It's my pleasure to have here on the call today, AngioDynamics' CEO, Jim Clemmer; and CFO, Stephen Trowbridge.

(Operator Instructions)

But with that, I'd like to hand it over to AngioDynamics.

James C. Clemmer
AngioDynamics, Inc. - CEO, President & Director

Thanks, [Soren]. And thanks for the folks at JPMorgan for inviting us to the conference this year. So before I begin, let me remind investors that what you'll hear from us today are our expectations. These are forward-looking statements and most investors know of the risk and forward-looking statements. So please do your diligence, listen to what we say today. Understand, again, we can't always predict the future in an accurate manner. So do your best diligence as you look forward to invest.

So let me tell you a little bit about AngioDynamics. If you look to our slide deck, you start on Slide 3. Our company is really going through what we're

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot